Clinical Trials

NCT07707895 | NOT_YET_RECRUITING | PHASE1/PHASE2
60 participants

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2026-08-26
Completion:
2030-04-26
Conditions
  • Small Cell Lung Cancer
  • Large Cell Neuroendocrine Lung Carcinoma
  • Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology
  • Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page